L. Frontini

4.3k total citations · 1 hit paper
82 papers, 2.0k citations indexed

About

L. Frontini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Electrical and Electronic Engineering. According to data from OpenAlex, L. Frontini has authored 82 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 22 papers in Electrical and Electronic Engineering. Recurrent topics in L. Frontini's work include Colorectal Cancer Treatments and Studies (24 papers), Cancer Treatment and Pharmacology (16 papers) and Gastric Cancer Management and Outcomes (15 papers). L. Frontini is often cited by papers focused on Colorectal Cancer Treatments and Studies (24 papers), Cancer Treatment and Pharmacology (16 papers) and Gastric Cancer Management and Outcomes (15 papers). L. Frontini collaborates with scholars based in Italy, France and Australia. L. Frontini's co-authors include Sandro Barni, Vincenzo Adamo, M. Marangolo, Francesco Di Costanzo, Cesare Gridelli, C. Boni, Elide Matano, Filippo de Marinis, A. Ceribelli and M. Clerici and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

L. Frontini

77 papers receiving 1.9k citations

Hit Papers

Phase III Randomized Trial Comparing Three Platinum-Based... 2002 2026 2010 2018 2002 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer
    2002 739 citations L. Frontini et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Frontini Italy 20 1.4k 1.1k 277 254 238 82 2.0k
Kristin Bergethon United States 12 818 0.6× 791 0.7× 594 2.1× 235 0.9× 289 1.2× 17 1.6k
Meghan J. Mooradian United States 19 1.8k 1.3× 1.2k 1.1× 472 1.7× 282 1.1× 156 0.7× 68 2.6k
Yoshifumi Shimada Japan 31 1.5k 1.1× 1.2k 1.2× 673 2.4× 318 1.3× 1.1k 4.5× 187 3.1k
C. Sturgeon United Kingdom 13 916 0.7× 341 0.3× 473 1.7× 323 1.3× 297 1.2× 28 1.6k
In Sil Choi South Korea 20 1.1k 0.8× 976 0.9× 388 1.4× 359 1.4× 241 1.0× 82 1.9k
Leyre Zubiri United States 22 1.3k 1.0× 450 0.4× 402 1.5× 287 1.1× 106 0.4× 56 2.0k
Victoria Villaflor United States 28 1.5k 1.1× 1.2k 1.1× 600 2.2× 404 1.6× 742 3.1× 132 2.9k
Stefano Guadagni Italy 24 606 0.4× 526 0.5× 201 0.7× 173 0.7× 791 3.3× 140 1.7k
Tetsuya Kusumoto Japan 21 600 0.4× 488 0.5× 402 1.5× 200 0.8× 485 2.0× 139 1.5k
Lavinia Spain United Kingdom 15 1.9k 1.4× 646 0.6× 304 1.1× 120 0.5× 159 0.7× 61 2.4k

Countries citing papers authored by L. Frontini

Since Specialization
Citations

This map shows the geographic impact of L. Frontini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Frontini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Frontini more than expected).

Fields of papers citing papers by L. Frontini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Frontini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Frontini. The network helps show where L. Frontini may publish in the future.

Co-authorship network of co-authors of L. Frontini

This figure shows the co-authorship network connecting the top 25 collaborators of L. Frontini. A scholar is included among the top collaborators of L. Frontini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Frontini. L. Frontini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rivetti, Angelo, S. Cadeddu, A. Lai, et al.. (2020). The first ASIC prototype of a 28 nm time-space front-end electronics for real-time tracking. Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano). 22–22. 4 indexed citations
2.
Gelsomino, Fabio, Valter Torri, Alberto Zaniboni, et al.. (2017). Sidedness influences prognosis in colon cancer patients receiving an adjuvant therapy. A GISCAD analysis from three randomized trials including 5234 patients. Annals of Oncology. 28. vi5–vi5. 2 indexed citations
3.
Graziano, Francesco, Annamaria Ruzzo, Eliana Rulli, et al.. (2016). Dihydropyrimidine dehydrogenase (DPYD) gene polymorphisms profiling in colon cancer patients treated with adjuvant chemotherapy in the randomized phase III TOSCA trial. Annals of Oncology. 27. iv1–iv1. 1 indexed citations
4.
5.
Cascinu, Stefano, Roberto Labianca, Carlo Barone, et al.. (2007). Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients With 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial. JNCI Journal of the National Cancer Institute. 99(8). 601–607. 71 indexed citations
6.
Guglielmi, Alfredo, Sandro Barni, Alberto Zaniboni, et al.. (2004). Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil. British Journal of Cancer. 91(8). 1428–1433. 1 indexed citations
7.
8.
Maïo, Massimo Di, Federica Perrone, Ciro Gallo, et al.. (2003). Supportive care in patients with advanced non-small-cell lung cancer. British Journal of Cancer. 89(6). 1013–1021. 19 indexed citations
9.
Cascinu, Stefano, Francesco Graziano, Sandro Barni, et al.. (2001). A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer. British Journal of Cancer. 84(4). 470–474. 40 indexed citations
10.
Gridelli, Cesare, Luigi Manzione, Francesco Perrone, et al.. (2001). Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study. British Journal of Cancer. 84(1). 38–41. 14 indexed citations
11.
Sobrero, Alberto, Alberto Zaniboni, Giovanni Luca Frassineti, et al.. (2000). Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study. Annals of Oncology. 11(11). 1413–1420. 15 indexed citations
12.
Gridelli, Cesare, L. Frontini, Federica Perrone, et al.. (2000). Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. British Journal of Cancer. 83(6). 707–714. 51 indexed citations
13.
14.
Nisticò, Cecilia, Carlo Garufi, Sandro Barni, et al.. (1999). Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: A high-activity, dose-dense weekly regimen for advanced breast cancer. Annals of Oncology. 10(8). 937–942. 28 indexed citations
15.
Cascinu, Stefano, Sandro Barni, Roberto Labianca, et al.. (1999). A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). British Journal of Cancer. 80(10). 1595–1598. 68 indexed citations
16.
Cascinu, Stefano, L. Frontini, G. Comella, et al.. (1999). Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). British Journal of Cancer. 79(3-4). 491–494. 4 indexed citations
17.
Labianca, Roberto, Stefano Cascinu, L. Frontini, et al.. (1997). High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study. Annals of Oncology. 8(2). 169–174. 20 indexed citations
18.
19.
Gasparini, Giulio, Orazio Caffo, Sandro Barni, et al.. (1994). Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.. Journal of Clinical Oncology. 12(10). 2094–2101. 133 indexed citations
20.
Frontini, L., et al.. (1978). [Traumatic rupture of the diaphragm caused by closed injury].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(1). 58–79. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristin Bergethon Breakdown of academic impact, for papers by Meghan J. Mooradian Breakdown of academic impact, for papers by Yoshifumi Shimada Breakdown of academic impact, for papers by C. Sturgeon Breakdown of academic impact, for papers by In Sil Choi Breakdown of academic impact, for papers by Leyre Zubiri Breakdown of academic impact, for papers by Victoria Villaflor Breakdown of academic impact, for papers by Stefano Guadagni Breakdown of academic impact, for papers by Tetsuya Kusumoto Breakdown of academic impact, for papers by Lavinia Spain
Rankless by CCL
2026